Trevor Stephen Barlowe, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Chronic | 2 | 2020 | 269 | 0.800 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 665 | 0.370 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1683 | 0.370 |
Why?
|
| RNA-Binding Proteins | 4 | 2017 | 1961 | 0.310 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3037 | 0.250 |
Why?
|
| Leukemia, Myeloid | 2 | 2017 | 742 | 0.240 |
Why?
|
| Vermont | 1 | 2019 | 92 | 0.190 |
Why?
|
| New Hampshire | 1 | 2019 | 189 | 0.190 |
Why?
|
| Leukemia, Experimental | 1 | 2018 | 270 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1390 | 0.180 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 77 | 0.170 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2020 | 766 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2015 | 74 | 0.140 |
Why?
|
| Patient Admission | 1 | 2019 | 1410 | 0.110 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 1181 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2018 | 3027 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 3457 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11833 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4716 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 23439 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9934 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7110 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2018 | 11910 | 0.050 |
Why?
|
| Hematopoiesis | 2 | 2018 | 1961 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 10094 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2017 | 33 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 15597 | 0.040 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2017 | 122 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 38732 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 2072 | 0.040 |
Why?
|
| Cell Survival | 2 | 2017 | 6288 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2015 | 428 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 67320 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 895 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1659 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 1063 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21684 | 0.030 |
Why?
|
| Animals | 6 | 2018 | 170849 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1157 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2159 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1178 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 4040 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3881 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10990 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2503 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3713 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2568 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18495 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 3103 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2103 | 0.020 |
Why?
|
| Humans | 6 | 2020 | 686663 | 0.020 |
Why?
|
| Mice | 3 | 2018 | 80803 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 3053 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 3116 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 9947 | 0.010 |
Why?
|
| Female | 4 | 2018 | 375459 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 17251 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 6323 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 60991 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 162271 | 0.000 |
Why?
|
| Male | 1 | 2016 | 352465 | 0.000 |
Why?
|